PressJanuary 12, 2021 MindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Digital Clinical Markers
PressJanuary 11, 2021 Cybin Partners with Kernel to Leverage its Breakthrough Neuroimaging Technology for Psychedelic Therapeutics
PressJanuary 8, 2021 COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care
PressJanuary 7, 2021 MindMed Closes Upsized Financing of CAD $92.1m (USD $72.7m) to Meet High Investor Demand
PressJanuary 6, 2021 Mind Cure Announces Build-Out of Digital Therapeutics, iSTRYM: A Technology Platform for Mental Wellness Optimization & Psychedelic Research
PressJanuary 4, 2021 Ehave, Inc. Files to List on the Canadian Stock Exchange and Applies to Upgrade to OTCQB Exchange
PressDecember 29, 2020 Better Plant’s Subsidiary NeonMind to Complete Fully Subscribed IPO and Commence Trading on Monday, January 4, 2021 under the symbol NEON
PressDecember 29, 2020 Mindset Further Expands Portfolio of Psychedelic Drug Candidates with Third U.S. Provisional Patent Application; 50 Total New Psychedelic Patent-Pending Compounds Synthesized
PressDecember 28, 2020 Red Light Holland Announces Exercise of Warrants for Gross Proceeds of Over $5 Million
PressDecember 23, 2020 Mindset Pharma to Commence Trading on the CSE on December 23, 2020 Under the Symbol “MSET”
PressDecember 22, 2020 MagicMed Industries Announces the Establishment of Psilocybin-Derivatives Portfolio and Launch of Candidate Selection Program
PressDecember 21, 2020 BetterLife Closes Acquisition of Second Generation Psychedelic Assets of Transcend Biodynamics LLC
PressDecember 18, 2020 MagicMed Industries Announces Closing of Upsized and Oversubscribed $8.1 Million Private Placement of Units Led by Gravitas Securities Due to Significant Investor Demand
PressDecember 16, 2020 Ehave, Inc. Announces KetaDASH for Ketamine Home Delivery and Purchase of Curedash Assets
PressDecember 15, 2020 PharmaTher Files U.S. Patent for Novel Combinations of Psilocybin and FDA Approved Drugs to Treat Neurological Disorders
PressDecember 14, 2020 Seelos Therapeutics Raises $10 Million In Private Placement of Senior Secured Convertible Note
PressDecember 11, 2020 MindMed Closes Upsized Financing of CAD $34.5m, Gross Proceeds Raised Since Company Founding Now Total CAD $121.4m (USD $94.8m)
PressDecember 11, 2020 Better Plant Subsidiary NeonMind Announces Filing of Final Prospectus in Connection with an Initial Public Offering